Evolus (EOLS) Liabilities and Shareholders Equity (2017 - 2026)

Evolus has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $220.6 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 3.41% year-over-year to $220.6 million; the trailing twelve-month figure through Mar 2026 stood at $894.3 million (down 1.65% YoY), and the FY2025 full-year result was $225.9 million, down 2.88% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $220.6 million, down from $225.9 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $233.8 million in Q2 2024, with the low at $160.2 million in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $207.0 million across 5 years, with a median of $219.0 million in 2025.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 30.88% — and 2024, when it surged 41.15%.
• Evolus' Liabilities and Shareholders Equity stood at $178.0 million in 2022, then rose by 6.19% to $189.0 million in 2023, then grew by 23.05% to $232.6 million in 2024, then decreased by 2.88% to $225.9 million in 2025, then dropped by 2.31% to $220.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $220.6 million (Q1 2026), $225.9 million (Q4 2025), and $219.0 million (Q3 2025), per Business Quant data.